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The mixed lymphocyte reaction (MLR)' is widely used as an in vitro analogue model to 
investigate  cellular  immunity  (1,  2).  In such  cultures,  responder lymphocytes of one 
mouse strain  are  plated  together with  allogeneic or semiallogeneic  (2,  3)  stimulator 
lymphocyte populations which have been  inactivated by irradiation  or mitomycin C. 
After 3-4 days, antigen recognition can be measured  (4,  5) by uptake of [3H]TdR into 
newly synthesized DNA of the responder cells (mixed lymphocyte culture  [MLC] test). 
Alternatively relative numbers of cytotoxic T lymphocytes (CTL) in the same cultures 
can be measured on day 4 or 5 using a 5'Cr release cytotoxicity test (6, 7). It has previously 
been shown by many authors (8-11) that macrophages (or A cells)  are necessary during 
the first 24 h  of an MLR as measured by the MLC test.  Macrophages have also been 
demonstrated to be required for the generation of CTL (12, 13). 
When more sensitive in vitro culture conditions were introduced by including 5 × 10 -~ 
M 2-mercaptoethanol (2-ME) in the standard culture medium (14-19), it appeared that 
macrophages in vitro have at least two functions: a viability promotion function appar- 
ently acting by conditioning of the medium and an antigen presentation function (18). It 
also became clear that under these improved culture conditions, A-cell depletion methods 
appeared not to be so efficient as before (17, 19). 
In this paper we have taken spleen cells from nude mice as a  source of non-T 
cells, since it is known that such suspensions contain functional A cells (20),  but 
no cytotoxic lymphocyte precursor (CLP) cells  (21). 
Below a simple assay system is described in which spleen cells from nude mice 
(nu/nu)  are used as a  source of non-T cells,  and limiting numbers of LN cells 
from normal littermates  (+/+  or nu/+)  are used as a  source of CLP cells.  It is 
shown that under optimal tissue culture conditions (including fetal calf serum 
[FCS] and 2-ME), a  synergism occurs that is different from a  feeder effect. The 
CTL cells responsible for the cytotoxicity are shown to be derived from the LN 
component.  Specificity  experiments  involving genetically different  responder 
cell mixtures demonstrated that synergism between the LN cells and the nu/nu 
spleen cells can occur even across major histocompatibility differences (includ- 
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ing/-region differences). This observation distinguishes our results from similar 
cell interactions where the interacting cells had to be syngeneic with respect to 
histocompatibility antigens (11, 22, 23). 
Materials and Methods 
Mice.  Homozygous  athymic nude mice (nu/nu)  and their heterozygous  normal littermates 
(nu/+) were bred in the animal facility at the Ontario Cancer Institute as described earlier (20, 
24). Two inbred strains were available: the original H-2 ~" strain RNC-nu/nu and an H-2 b strain B6- 
nu/nu obtained by backcrossing RNC-nu/nu onto the C57BL/6J background (24). The RNC strain 
was used in generations FIs-F22  of inbreeding, the B6 congeneic strain in generations FH-F~4 of 
backcrossing. F1 animals, when needed, were obtained by mating RNC-nu/nu males with B6-nu/+ 
females. 
C57BL/6J x  DBA/2J (B6D2FI) mice and C3H/HeJ  x  DBA/2J (C3D2FI) mice were obtained from 
The Jackson Laboratory, Bar Harbor, Maine. DBA/2 StCrlBR mice were purchased from Cana- 
dian Breeding Farm,  St.  Constant,  Quebec,  and C57BL/6J  x  C3H/He  (B6C3F0 mice from Bio- 
Breeding Laboratories, Ottawa. Male or female mice were used. A control experiment showed that 
there was no difference in the cytotoxic immune response with respect to viable cell input between 
male or female responder cells,  although the cell yield per spleen was lower for female mice. 
Within a  given experiment, only male or only female mice were used. 
Cell Suspensions and Media.  Spleen cell suspensions or lymph node cell suspensions from 8- 
12-wk-old mice were prepared aseptically by mincing the organs with scissors and passing them 
through a  wire mesh (60 gauge) into cold "standard medium" (a-MEM (Flow Laboratories, Inc., 
Rockville, Md.) with 10% (vol/vol) heat-inactivated (56°C for 45 min) FCS, 20 mM HEPES buffer, 
and 5  ×  10 -5 M  2-ME).  The suspensions were always layered over and washed through FCS as 
described by Shortman et al.  (25) to remove aggregates and fine cell debris. The medium for the 
micro-5~Cr release test Cassay medium") was  a-MEM containing 10%  (vol/vol) heat-inactivated 
FCS and 20 mM HEPES buffer. No difference in the specific release was found, however, when 
standard medium was used instead of assay medium throughout the 5~Cr release test. 
Tumor Cell Lines and  slCr-Labeling.  H-2 d target cells in the slCr release assay were P815 
mastocytoma cells (26) which were maintained in ascites form by weekly in vivo passage in DBA/2 
mice.  To  label  target  cells  for  the  s;Cr  release  test,  ascitic  mastecytoma  fluid  was  diluted 
(approximately 1:5) with PBS and washed once. The pellet was resuspended in PBS, and the cell 
concentration was estimated using a hemocytometer. For a standard assay (4-5 microtiter plates) 
3 ×  107 mastocytoma cells in 1 ml were labeled with 1 mCi s~Cr as sodium chromate (Radiochemi- 
cal Centre, Amersham, England) for 50 min at 37°C in 10% CO2 in air. The labeled cells were then 
washed  four  times  with  assay  medium  at  room  temperature,  and  the cell  concentration was 
adjusted to give 5  ×  l0  s cells/ml. Of this, 0.1 ml was added to each well in the micro-S|Cr release 
test. Two other target cells, both maintained in tissue culture, were KHT tumor cells (H-2 k) which 
were kindly provided by Dr. D. A. Clark, and EL-4 (H-2 ~) cells which were obtained from Dr. H. R. 
MacDonald, London, Ontario. For labeling these target cells, conditions were as described for P815 
above. 
Viability Test.  All cell viability measurements were done using two fluorescent stains: ethid- 
ium bromide, which stains dead nucleated cells; and fluorescein diacetate,  which stains viable 
nucleated cells  (27).  Using a  fluorescence microscope  (Zeiss/Oberkochen, West Germany) with 
incident illumination, the direct percentage of viable nucleated cells could be measured without 
counting red blood cells. To get good counting statistics, 400 or more cells per sample were always 
counted. 
Irradiation.  Stimulator cells in one-way mixed lymphocyte cultures were heavily irradiated 
(1,500 rads) using a  ~37Cs irradiator at a dose rate of 102 rads/min (28). Cell suspensions were kept 
in standard medium at 4°C during irradiation. 
Anti-O-Serum  Treatment.  Two different anti-t~ serum preparations were used,  a  rabbit anti- 
mouse brain-associated (RAMB) serum as described by Golub (29) and an AKR anti-0c:;H serum as 
described by Reif and Allen (30). The former was purchased from Cedarlane Laboratories, Hornby, 
Ontario Cantimouse T-cell serum" lot no. T-111), the latter from Bionetics Laboratories, Kensing- 
ton, Md.  (lot 231-55-1).  The unabsorbed RAMB antiserum had a 50% lysis titer of 1:32, the mouse R.  M.  SCHILLING,  R.  A.  PHILLIPS,  AND  R.  G.  MILLER  243 
anti-0c3H antiserum a 50% lysis  titer  of 1:64,  both as measured by a sLCr  release assay with LN 
target cells and simultaneous  EB-FDA  viability  test. After liver absorption  (31) specificity 
controls  were done using a titer  of  1:10  of  either  anti-0  serum and testing  BM, thymus, or LN. It 
was found that both sera lysed 1% BM, 99% thymus, and 65-70% LN when tested  in an EB-FDA 
viability test. Functionally, these sera (plus complement) destroyed  CLP cells,  but lost this 
activity  when absorbed with thymus. 
Guinea pig serum Clow-tox," Cedarlane Laboratories) was used as a source of complement. 
This was absorbed with mouse spleen cells  syngeneic to  the cell  suspension to  be treated,  filtered 
through a 0.2-/~m  Millex filter  (Millipore  Corp.,  Bedford, Mass.) and stored  at -20°C until  use.  For 
anti-0  serum treatment cells  were incubated with anti-0  serum (final  dilution  of  1:10)  in 6% BSA- 
phosphate-buffered saline  (PBS) at  a concentration of  107  cells/ml  for  30 min at  4°C.  The cells  were 
then washed once with 10  ml of  5% BSA-PBS, resuspended in  either  5% BSA-PBS (no  complement 
control)  or in a 1:6  dilution  of  guinea pig serum, incubated at  37°C for  45 min in an atmosphere of 
humidified  10% CO2 in air,  washed once in 2-ME free standard medium and once in standard 
medium, and resuspended to the desired concentration in standard medium. 
Alloantisera.  For one experiment an  anti-H-2  ~ alloantiserum was needed. This  was made 
according to the injection schedule of Gregory et al. (32) with the modification that B6C3F~ spleen 
cells were injected (instead of B6 cells) into C3H/HeJ animals. The resulting ascites containing 
anti-H-2 b antibodies was absorbed twice with RNC-nu/+  spleen cells. The 50% lysis point using 
the treatment protocol, as described for the anti-0 serum treatment, was found to be 1:8 with (B6 × 
RNC)F~  nu/+  LN cells. Controls with RNC-nu/+  LN cells showed that there was no toxic effect 
against H-2 ~" cells at a 1:2 final titer, whereas 98% of F~ cells were killed under these conditions. 
In Vitro Immunization.  Responder cells (usually 3  x  105-2 ×  106 viable cells) were mixed with 
2  ×  10  ~ nucleated irradiated (1,500 reds) stimulator cells in 75-ram plastic tubes (no. 2058 Falcon 
Plastics, Oxnard, Calif.) containing 3 ml standard medium. In all experiments the strains for 
responder and  stimulator  cells were  chosen as  to  avoid  "backstimulation"  (3,  33).  Thus  the 
stimulator cells were always a hybrid strain (e.g., B6D2F~), whereas the respender cells were one 
of the parents (e.g., B6  when the target cell was H-2 d).  Cultures were set up in duplicate and 
incubated for 4 days upright (loosely capped) at 37°C in a humidified atmosphere of 10% CO2 in air. 
Micro-SLCr Release Test.  A slightly modified micro version (34) of  the original 5~Cr release was 
used. This micromodification avoids any centrifugation and allows one to assay for the cytootoxic 
activity of individual cultures.  Briefly,  it was performed as follows: The supernate from each 
culture to be assayed was removed using a  specially designed pipette such that the pellet was 
reproducibly  (coefficient of variation  of 0.026)  left  in  0.28  ml  medium.  The  pellet  was  then 
suspended, 0.1 ml transferred into the first well of a  microtitor tray (Linbro IS-FB-96-TC), and 
another 0.1 ml transferred into the second well containing 0.1 ml assay medium to give the first 
dilution. After mixing, 0.1 ml of this well was carried over to the next well for the second dilution, 
etc. A separate dilution series was made for each culture. Preliminary experiments showed that it 
was not necessary to wash the cultured cells before the measurement of  cytotoxicity. Next 0.1 ml (5 
×  104 cells) of the labeled target cell suspension (see above) was added to each well and the trays 
incubated for 4 h at 37°C in a humidified atmosphere of 10% CO2 in air. Then, 0.1 ml of supernate 
was collected from each well using a  100 ~l Eppendorf  pipette placed into a special stand to insure 
that the distance between the pipette and the bottom of the microtiter well was constant, thus 
avoiding accidental sucking up of target cells. Control cultures with only responder cells or only 
stimulator cells were added at a fourfold dilution to 5 x  104 target cells to estimate the background 
5~Cr release, which varied from 6-12% of the total 5~Cr incorporated. The total releasable 5~Cr was 
estimated by diluting 0.1  ml of the target cells into 1.5 ml of counting fluid  (1% acetic acid in 
distilled water) which usually gave 75-80%  release. Counts were performed in an LKB Wallac 
80,000 automatic gamma sample counter. Under the labeling conditions described above, 5 ×  104 
cells gave 8,000-11,000  cpm. 
Quantitation of the relative frequency of cytotoxic effector cells was done as described else- 
where (7). Briefly, this is as follows: Specific 5~Cr release, p, in each microtiter well was calculated 
as (observed counts -  background)/(total releasable -  background). It can be shown (7) that the 
fraction of target cells lysed is given by f  =  1 -  e-~,  where N  is the total number of sensitized 
cells,  a  is proportional to the frequency of CTL,  and t  is the assay time.  Under appropriate 
conditions (t ~  1.5 h, sensitized lymphocyte to target cell ratio not too high), f  = p,  so that Na 244  NON'T  CELLS  IN  THE  GENERATION  OF  CYTOTOXIC  T  LYMPHOCYTES 
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Fro.  1.  Titration  curves of the 5'Cr cytotoxicity test for three different day 4  cultures 
demonstrating synergism between nu/+  LN cells and nu/nu  spleen cells. (A) 1 ×  10  ~ B6 nu/ 
nu  spleen cells as responder cells; (O) 2 ×  105 B6 nu/+  LN cells as responder cells; (Q) 2 × 
105  B6  nu/+  LN  cells cocultured with  1  ×  106  B6 nu/nu  spleen cells. Each culture also 
contained 2 ×  10  ~ irradiated (1,500 rads) B6D2F1 spleen cells as stimulator cells. The target 
cells were P815  mastocytoma cells. 
=  _  1 In (1  -  p  ). All of the data below (except for Fig. 1) are presented in terms of N a rather than 
t 
p. By comparing Fig. 1 with Fig. 2 or 3 one can see that each titration curve of the type shown in 
Fig.  1 is represented by a  single Na value, directly proportional to the number of CL in that 
culture. 
Statistical  Analysis.  Using the above analysis, each titration curve in the micro-5'Cr release 
test could be reduced to give one Na value using the best fit to the data points.  We observed 
empirically that titration curves of replicate cultures with small Na values showed a  greater 
dispersion than  replicate  cultures  with  high  Na  values.  To  quantitate  this  observation we 
analyzed 53 titration curves, each of which had been done in triplicate or quadruplicate. For each 
set of replicates, the arithmetic mean Na and the dispersion (coefficient of variation [CV])  was 
calculated.  A  negative linear relationship between the logarithms of the Na  values and  the 
coefficient of variation  was  found:  log,o  (CV)  =  -0.361  log,o  (Na)  -  0.925.  The  correlation 
coefficient for this regression line was 0.95.  We could therefore use this relationship to estimate 
the CV for the mean Na of replicate cultures. Error bars shown throughout are 95% confidence 
limits calculated  from this formula.  In  the remainder of this paper,  only Na  values  will be 
presented. Each has been derived from titration curves similar to those shown in Fig.  1.  For 
convenience, they are always given multiplied by 104. A numerical value for "cytotoxic activity/ 
culture" refers to this parameter. 
Results 
Synergism  Between  Small  Numbers  of  nu/+  LN  Cells  and  nu/nu 
Spleen.  Fig.  1  shows  ~'Cr  cytotoxicity titration  curves  for  three  different R.  M.  SCHILLING,  R.  A.  PHILLIPS,  AND  R.  G.  MILLER  245 
cultures. In each culture either 2 x  105 B6-nu/+ LN cells, or l0  s B6-nu/nu spleen 
cells, or both together were cultured along with 2  ×  106 irradiated  (1,500  rads) 
B6D2F1 spleen cells. On day 4, various dilutions of each culture, as shown in the 
figure, were titrated for their ability to lyse cells bearing D2 alloantigens using 
51Cr-labeled P815 cells. It is clear from the figure that the nu/nu spleen cells, 
although inactive when cultured separately, appear to synergize with nu/+ LN 
cells  to  give  a  much  larger  cytotoxic  response  than  that  of nu/+  LN  cells 
cultured alone. 
Several possible procedures exist for quantitating the activity of each culture 
and thus assessing more directly the degree of synergism. We have chosen to do 
this by calculating from each titration  curve the relative number of cytotoxic 
lymphocytes  present  in  the  culture  according  to  the  procedure  outlined  in 
Materials  and  Methods  and  described  in  detail  elsewhere  (7).  This  analysis 
yields a numerical value for a  parameter Na which is proportional to the total 
number of cytotoxic lymphocytes in the culture.  For the nu/+ LN curve, Na = 
0.012 and for the nu/+ LN  +  nu/nu spleen curve, Na  =  0.056, or 4.7 times as 
active. 
Fig. 2 shows the results of an experiment in which varying numbers of nu/+ 
LN cells were cultured either alone or mixed with a constant number (106) ofnu/ 
nu  spleen  cells.  All  cultures  also contained  a  constant  number  of irradiated 
B6D2F1 spleen cells as stimulator cells. After 4 days of incubation, each culture 
was titrated separately to give Na x  104/culture values. The results show that, 
for high numbers of nu/+ LN cells, addition of syngeneic nu/nu spleen cells has 
little or no effect on the yield of cytotoxic effector cells.  In contrast,  for lower 
numbers of nu/+ LN cells per culture, there is a  marked synergistic effect. 
Fig. 3 shows the results of a similar experiment but in which the nu/nu spleen 
cells  instead  of the  nu/+  LN cells  were titrated.  Varying  numbers  of nu/nu 
spleen cells were cultured either alone or mixed with a constant small (2 x  10  ~) 
number of nu/+ LN cells. The nu/nu spleen cells are themselves inactive at all 
concentrations but, when cultured with the nu/+ LN cells, produce increasing 
activity with increasing number until a plateau is reached corresponding in this 
experiment to a  synergism of about 10-fold. 
Genetic Analysis of Synergism.  The synergistic interaction demonstrated in 
Figs. 1-3 could be interpreted in two ways: (a) As the number of nu/+ LN cells 
cultured  is  decreased,  a  subpopulation  of cells  necessary  in  the  induction  of 
cytotoxic effector cells is diluted  out.  This  subpopulation  is present in nu/nu 
spleen and is responsible for the synergism. (b) Alternatively, the increased cell 
density brought about by addition of nu/nu spleen cells improves tissue culture 
conditions so that small numbers of nu/+ LN cells can respond better. 
To distinguish between these two possibilities, an approach based on genetic 
differences in the population cultured was taken.  If nu/nu spleen cells have a 
specific role  in  the  induction  of cytotoxic effector cells  under  the  conditions 
described above, then the synergism should be influenced by the genetic rela- 
tionship  between  the  nu/nu  spleen  cells  and  the  stimulator  cells.  Varying 
numbers of nu/nu spleen cells from B6 (H-2b),  RNC (H-2k), and the F1 hybrid 
between them were tested for their capacity to synergize with constant small 
numbers  of B6 nu/+  LN cells.  All cultures  also contained  irradiated  C3B6F1 246  NON-T  CELLS  IN  THE  GENERATION  OF  CYTOTOXIC  T  LYMPHOCYTES 
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Fla.  2.  Demonstration of synergism in  cultures containing as responder cells varying 
numbers of B6 nu/+ LN cells in the presence or absence of 106 B6 nu/nu spleen cells. (©) nu/ 
+ LN cells alone; (Q) mixtures of varying nu/+ LN cells and 1 ×  10  e nu/nu spleen cells. All 
cultures, done in duplicate, also contained 2  ×  10  e irradiated (1,500 rads) B6D2FI spleen 
cells as stimulator cells. Target cells were P815 (H-2 d) mastocytoma cells. Cultures contain- 
ing 10  e nu/nu  spleen cells alone as responder cells gave no activity (not shown). 
spleen cells (H-2  blk) as stimulators and were assayed for cytotoxic activity after 4 
days of culture using KHT (H-2  k) target cells. If the synergism were due to some 
feeder effect of the nu/nu  spleen cells, then all the mixtures should synergize 
equally well, since all of the cultures contained the same B6 nu/+  LN compo- 
nent. The results, shown in Fig. 4, indicate that this is not the case. The mixture 
of B6 nu/+  LN and B6 nu/nu  spleen shows the largest synergism.  This is the 
only combination in which the mixture is syngeneic and in which both partners 
can recognize the same alloantigen.  A similar phenomenon is seen when vary- 
ing numbers of B6 nu/+ LN cells are cultured with 10  e nu/nu spleen cells from 
different sources, as is seen in the experiment of Fig. 5. 
Attention  was focussed on  those  conditions  that  produce maximum  syner- 
gism, i.e., combination of small numbers of nu/+ LN cells with large numbers of 
nu/nu spleen cells. One other responding cell mixture was included: RNC nu/+ 
LN and RNC nu/nu  spleen. Three additional types of stimulator cells and two 
additional target cells were included.  The results of one experiment are shown 
in Fig. 6. 
Several points are worth noting: (a) Groups 1-3 repeat the observation of Figs. 
4 and 5, i.e. the synergism is obtained only in group 1, in which nu/nu and nu/+ R.  M.  SCHILLING,  R.  A.  PHILLIPS,  AND  R.  G.  MILLER 
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FIG. 3.  Demonstration of  synergism in cultures containing a constant small number, 2 x 
105,  of  B6 nu/+ LN cells  and increasing numbers of  B6 nu/nu spleen cells.  (X) On ordinate 
shows activity  of  2 x 10  s  nu/+ LN cells  alone; (©) nu/nu  spleen cells  alone; (O) mixtures of 
increasing  nu/nu spleen cells  and 2 x 10  s  nu/+ LN cells.  All cultures also  contained 2 x 106 
irradiated (1,500  rads) B6D2FI spleen cells  as stimulator cells  and were assayed on day 4 
against P815 (H-2  d) mastocytoma target cells. 
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cells can both recognize the same alloantigen. Note the controls below showing 
that the synergism in groups 2 and 3 is very small. The cultures of groups 5-7 
are  identical  to  those  of groups  1-3  except  that  here  we  used  target  cells 
syngeneic to the other parent of  the F1 stimulator cells, that parent syngeneic to 
the nu/+ population. All responses are zero, suggesting that addition of nu/nu 
cells which are syngeneic, semisyngeneic, or allogeneic to the nu/+ cells cannot 
facilitate recognition of self-antigens. (b)  The  semiallogeneic and  allogeneic 
responder cell combinations are also active when stimulated by and assayed 
against third  party  alloantigens (H-2d).  For  example,  this  is  evident when 
groups 2 and 3 are compared with groups 10 and 11. (c) The collaboration is not a 
function of the stimulator cells since groups 9-12  (B6D2F1 spleen as stimulator) 
are similar to groups 13-16  (P815 as stimulator). 
Origin and Nature of the Cytotoxic Effector Cells.  The additional cytotoxic 
effector cells seen in synergizing cultures might be partly derived from nu/nu 
spleen cells. To test this possibility, cultures of  parental and F1 mixtures of nu/+ 
LN and nu/nu spleen cells were set up against third party alloantigens. These 
mixtures have the advantage that one can specifically kill the F1 cells without 
harming the other cell partner by using a specific alloantiserum. The results of 248  NON-T  CELLS  IN  THE  GENERATION  OF  CYTOTOXIC  T  LYMPHOCYTES 
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FIG.  4.  Demonstration that synergism varies with the genetic origin of the nu/nu spleen 
cells: nu/nu spleen cell dose-response curve. Constant numbers (2 x 105)  of  B6 nu/+ LN cells 
and varying numbers of genetically different nu/nu spleen cells were cultured together and 
assayed on day 4.  Stimulator  cells for all cultures  were irradiated  (1,500 rads) C3B6F~ 
spleen cells. Target cells were KHT (H-2k).  (X) On ordinate 2 × 105 nu/+ LN cells cultured 
alone. Control cultures with B6, RNC, or FI nu/nu spleen cells alone (data not shown) gave 
no activity.  (O) Mixture of nu/+ LN cells with B6 nuinu spleen cells; (©) mixture of nu/+ 
LN cells with (RNC × B6) F~ nu/nu spleen cells; (A) mixture ofnu/+ LN cells with RNC nu/ 
nu spleen cells. 
one  experiment  are  shown in  Fig.  7.  Here,  day 4  cultures  were treated  with 
specific anti-H-2  b alloantisera  immediately before doing the  51Cr release  test. 
This alloantiserum should destroy cytotoxic activity derived from (RNC  ×  B6) 
FI cells, but not RNC cells.  It was observed (Fig.  7) that the cytotoxic activity 
was destroyed only when the LN cells were of F1 origin. Thus, all the cytotoxic 
activity is derived from the nu/+  LN cells, and no detectable activity comes from 
the nu/nu  spleen cells. 
To confirm that in a  synergizing culture all the effector cells are T  cells,  we 
treated the effector cells with anti-Thy-1.2 (AKR anti-0c3H) serum before the ~lCr 
release test.  The results  (Fig. 8, groups 1-3) show that all the cytotoxic effector 
cells are Thy-l.2 positive. In the same experiment nu/nu  spleen cells were added 
to  nu/+  -  nu/nu  spleen  cultures  on day 4 just  before the  5~Cr release  test  to R.  M.  SCHILLING,  R.  A.  PHILLIPS,  AND  R.  G.  MILLER  249 
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Fxo.  5.  Demonstration that synergism varies with the genetic o~gin of the nu/nu spleen 
cells: nu/+ LN dose response curve. Varying numbers of B6 nu/+ LN cells and constant 
numbers (106)  of genetically different nu/nu spleen cells were cultured together and assayed 
on day 4. Stimulator cells for all cultures were 2 x  l0  s irradiated (1,500 rads) C3B6FI spleen 
cells.  Target cells were KHT (H-2~9.  Control cultures with 1  ×  l0  s B6, RNC,  or F~ nu/nu 
spleen cells as responder cells showed no activity (data not shown).  (©) B6 nu/+  LN cells 
alone; (1) mixture of nu/+  LN cells with B6 nu/nu  spleen cells;  (A) mixture of nu/+  LN 
cells with (RNC  x  B6) FI nu/nu spleen cells; (X) mixture ofnu/+  LN cells with RNC nu/nu 
spleen. 
determine whether the nu/nu spleen cells must be present for all of the 4-day 
culture period to obtain synergism.  It can be seen (groups 4 and 5, Fig. 8) that 
late addition of nu/nu spleen cells produced no change in the cytotoxic activity 
over that measured for nu/+  LN cells alone. 
To  find  out  whether  the  interacting  cell  types  in  the  induction  phase  of 
cytotoxic lymphocyte production from mixtures of nu/+  LN and nu/nu  spleen 
cells  were  each  of T-cell  origin,  we  treated  each  component  separately  with 
RAMB serum before mixing with the other cell component.  The cell mixtures 
were then cultured for 4 days and assayed for cytotoxic activity.  As shown in 
Fig. 9, four different absorption controls were included to test the specificity of 
the antiserum.  Clearly, the cell provided by the nu/+ LN is a  T cell, since the 250  NONoT  CELLS  IN  THE  GENERATION  OF  CYTOTOXIC  T  LYMPHOCYTES 
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Fro.  6.  Genetic relationships required to obtain synergism.  Cultures contained  2  x  106 
C3B6F1,  B6D2FI, or C3D2FI spleen cells or 104 P815 mastocytoma cells as stimulator cells. 
In the cultures with spleen stimulator cells, 3  ×  105 nu/+ LN cells were taken; in cultures 
with P815 stimulator cells, 6 x  l0  s nu/+ LN cells. For nu/nu spleen, 8 ×  105 viable cells were 
always taken. 
cytotoxic activity of the antiserum is absorbed both by thymus and nu/+ spleen, 
but not by nu/nu spleen or nu/+ bone marrow. In contrast, when the same batch 
of absorbed sera was used with nu/nu spleen cells, a different pattern was found 
(Fig.  9).  The unabsorbed serum produced a  slight reduction in activity. This 
does not, however, appear to be due to an anti-Thy-l.2 activity in the serum as 
nu/nu  spleen absorbed this cytotoxic activity as effectively as nu/+  thymus. 
Similar results were found using a mouse AKR anti-ec3H serum with the same 
absorption controls (data not shown). It is concluded, therefore, that the active 
cell type in nu/+  LN is Thy-l.2 positive, and the active cell in nu/nu spleen is 
Thy-l.2 negative. R.  M.  SCHILLING,  R.  A. 
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Demonstration using alloantisera that effector cells come from the nu/+  LN cell 
251 
population and  not the nu/nu  spleen cell population.  Day  4  cultures were treated with 
alloantiserum and complement to determine the origin of the effector cells. Cell numbers 
are given in millions of viable cells. Each culture also contained 104 irradiated (1,500 rads) 
P815 mastocytoma cells as stimulators. Target cells in the micro-5~Cr release test were P815 
cells (H-2").  The anti-H-2  b serum (a.I-I-2  b) was used at a  1:2 dilution, complement at a  1:6 
dilution. 
Discussion 
We have demonstrated that there is a synergism between non-T and T cells in 
the in vitro generation of CTL under optimized culture conditions which include 
2-ME.  We interpret our data as indicating that non-T cells play an obligatory 
role in the generation  of CTL from their progenitors  (CLP), which are T  cells 
(35).  This  interaction  leads to the  activation  of CLP and  the  antigen-specific 
production of CTL. It is stressed that the interaction between non-T cells and T 
cells is possible across major histocompatibility differences including/-region 
differences. It is also important to note that the nu/+ LN may, in fact, provide 
two unique T cells, one of which is the CLP and the other of which amplifies the 
response of the CLP (36). 252  NON-T  CELLS  IN  THE  GENERATION  OF  CYTOTOXIC  T  LYMPHOCYTES 
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FIG.  8.  Demonstration that all effector cells in synergizing cultures are T cells (groups 1- 
3), and that addition of nu/nu  spleen cells to the cultures just before the cytotoxicity assay 
has no effect on the measured cytotoxicity (groups 4-5). All cultures also contained 2 x  106 
irradiated (1,500 rads) C3D2F, spleen cells as stimulator cells and were assayed using P815 
mastocytoma cells as target cells. 
Exclusion of Simple  Explanations for Synergism.  It  has  been  shown  by 
Pierce et al.  (18) that macrophages have two functions in an in vitro immune 
response to Sheep red blood cells (SRBC), a viability promotion function and an 
antigen  presentation  function.  The viability promotion function can be dupli- 
cated by 2-ME as shown by various authors  (14-19). Broome and Jeng (16) also 
showed that  2-ME-like conditioned  medium can promote the growth of L1210 
cells which otherwise would not grow in Eagle's basal medium.  We controlled 
for these growth-promoting effects by optimizing the FCS concentration and by 
including 2-ME. Preliminary experiments showed that 10% FCS, 5 ×  10  -5 M 2- 
ME, and 3 ml total culture volume were optimal for 4-day cultures as described 
in this paper. In addition, the genetic studies showed that addition of allogeneic 
or semiallogeneic nude spleen cells to (nu/+)  LN cells increased CTL in only R.  M.  SCHILLING,  R.  A.  PHILLIPS,  AND  R.  G. 
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Demonstration  that  treatment  (TR) of nu/+  LN,  but  not  nu/nu  spleen,  with 
RAMB serum  plus complement  before setting up cultures abolished  cytotoxic effector cell 
activity. Various absorption controls for the RAMB serum are shown. Synergistic activity of 
untreated mixtures has been arbitrarily set equal to 100 (corresponding to 5,960 Na  x  10~/ 
culture units).  In additiSn to the cell numbers indicated all cultures also contained 2  ×  10  e 
irradiated  (1,500  rads) B6D2F,  spleen  cells  as stimulator  cells.  Effector cell activity  was 
assayed on day 4 using P815 mastocytoma  cells. 
some  cultures  in  a  manner  inconsistent  with  the  sole  effect  being  that  of 
viability promotion (Figs.  4-6).  Viability tests of these 4-day cultures revealed 
that all  of the groups had a  viability  of 30-40%,  although both their relative 
cytotoxicity and total cell yield showed big differences in the same experiment 
(Figs. 4-6).  We conclude, therefore, that under the culture conditions described 
above,  cultures  are  saturated  for  the  viability  promotion  function  of macro- 
phages and any additional activity must be due to some other mechanism. 
One other such mechanism could be a mitogenic effect  (37).  It is conceivable 
that  allogeneically  stimulated  nude  spleen  cells  or nu/+  LN  cells  produce  a 
mitogen that "amplifies" the CLP activation. However, this does not seem to be 
the case. Compare, for example, groups 1, 2, and 3 of Fig. 6: cytotoxic activity of 
groups  2  (both  nu/+  and  nu/nu  receiving  H-2-difference  stimulation)  is  the 
same as group 3 (only nu/+ receiving H-2-difference stimulation) and much less 
than group 1. 
Another  mechanism  of activation,  namely  backstimulation  (3,  33),  can  be 
excluded as accounting for the synergism, since all nu/+ LN - nu/nu spleen cell 
mixtures have been expressly chosen to avoid this phenomenon. In some cases, 254  NON-T  CELLS  IN  THE  GENERATION  OF  CYTOTOXIC  T  LYMPHOCYTES 
this  required using P815 cells  as  stimulator cells  (38)  instead of  spleen cells  (e.g., 
groups 9-12,  Fig.  6).  The allogeneic responder cell  mixtures used (e.g.,  groups 2, 
6, and 10, Fig.  6) are unlikely to be affected  by backstimulation, because RNC 
nu/nu  spleen cells  lack T cells  (24)  which would be required to recognize the B6 
nu/+  LN cells  (3,  24).  In  these cultures,  stimulator-responder  backstimulation is 
controlled by taking F~ stimulator cells.  In Fig. 6, the only groups in which 
backstimulation might be a problem are groups 14 and 15. These only served as 
controls in the comparison of groups 9-12 and 13-16 to demonstrate that P815 
cells  are equivalent to spleen cells  in their  function as stimulator cells. 
We  conclude that the cause of the synergism  is not of a trivial nature 
(viability  promotion, mitogenic effect,  backstimulation),  but due to obligatory 
cell interactions between the nu/+ LN and nu/nu spleen cells. 
Origin and Properties of Cytotoxic Effector Cells.  Since it is established that 
nu/nu spleen cells cannot produce cytotoxic effector cells in MLC cultures  (12, 
24, and Fig. 3) one might expect a  priori that the effector cells in cell mixtures 
between nu/+ LN and nu/nu spleen are derived from the LN component. On the 
other hand  it might  be possible that  precursor cells in nu/nu  spleen  (39)  are 
activated  by T  cells  or  by T-cell  factors  (39-41)  from  the  nu/+  LN  cells  to 
differentiate  into  CTL.  Another  possibility  would  be  the  development  of a 
different effector cell mechanism in addition to CTL, e.g., A cells (42), "armed" 
macrophages (43, 44), or antibody-dependent lysis (45). All of these possibilities 
are excluded by the results of Fig. 7, where parent-F1 cell mixtures were treated 
with alloantiserum  and complement immediately before the micro-51Cr  release 
test.  If one of the above mechanisms were active, one should have seen some 
decrease of the activity when the cell mixture with F~ nu/nu spleen was treated. 
However, no change was seen (Fig. 7). On the other hand, all of the activity was 
destroyed when the cell mixture containing F~ nu/+ LN cells was treated (Fig. 
7). This demonstrates that all the effector cells are derived from the LN cells, but 
does not bear  on the  question  of what  the  nature  of the  effector cells  is.  In 
previous publications (13, 46) it was shown that CTL from normal MLR cultures 
are Thy-1 positive and that they lyse target cells specifically. To test whether or 
not the  effector cells  of synergistic  cell mixtures  are  T  cells,  we treated  cell 
mixtures  of LN cells after 4 days of culture with anti-Thy-1  and complement 
immediately before the micro-51Cr  release test. As shown in Fig. 8 (groups 1, 2, 
and 3) all of the activity was destroyed, indicating that all the cytotoxic activity 
was due to T cells. In Fig. 6 (compare groups 1, 4, 5, and 8) it is shown that this 
cytotoxic activity is specifically directed only against target cells carrying the 
same antigens  against  which the effector cells have been sensitized.  We con- 
clude  from  this  that  the  effector cells  produced  appear  to  be  identical  with 
respect to two tested properties (Thy-1 antigen,  specific lysis) to CTL developed 
in normal MLC cultures. 
Properties of Active Cells in nu/nu Spleen.  As shown in Fig.  9,  treatment 
with nu/nu spleen-absorbed RAMB serum before culture destroyed all the nu/+ 
LN cell activity but none of the nu/nu spleen cell activity. Similar results were 
obtained  with  liver-absorbed  AKR anti-0c.~H serum  indicating  to  us that  the 
active subpopulation(s) in nu/nu spleen are not T cells. 
Does the active cell type of nu/nu  spleen have specific antigen  recognizing R.  M.  SCHILLING,  R.  A.  PHILLIPS,  AND  R.  G.  MILLER  255 
function? This  question was tested in  Fig.  6.  As indicated above,  syngeneic 
responder cell mixtures showed that antigen recognition and target cell lysis 
were antigen specific (groups 1, 4,  5,  and 8 in Fig.  6). Two special cases with 
semiallogeneic and allogeneic responder cell mixtures were of interest to  us 
because we saw no synergistic response. In the allogeneic responder cell mixture 
(groups 2  and 6),  RNC  nu/nu  spleen cells recognize H-2  b antigens of the F~ 
stimulator cells, but B6 nu/+ LN cells recognize H-2  k antigens. We consider that 
this explains why there is no synergism against either KHT (H-2 k) or EL-4 (H- 
2 ~)  target cells.  In the other special  case with  semisyngeneic responder cell 
mixtures (groups 3 and 7, Fig. 6) there is no antigeneic stimulation of the F~ nu/ 
nu spleen cells since they are syngeneic to the stimulator cells, perhaps explain- 
ing why there is no synergism in this combination. In contrast, however, the 
same responder cell mixtures, when stimulated by a third party antigen which 
both  components  of the  mixture  can  recognize,  showed  marked  synergism 
(groups 10 and 11, Fig. 6). 
In conclusion, these data are consistent with the hypothesis that the active 
cell type of nu/nu  spleen has specific antigen-recognizing function. Collabora- 
tion  between the  nu/nu  spleen  cells  and  the  nu/+  CLP  requires that  both 
recognize  the  same  antigen.  Collaboration  is  possible  across  an  allogeneic 
difference including/-region differences, but only against a third party antigen. 
This finding distinguishes our results from those of Rosenthal et al.  (11, 22, 
23) who found that, in responding to soluble protein antigens, the cooperation 
between macrophages and T lymphocytes of guinea pigs required identity at the 
major histocompatibility locus.  The difference may be related to different re- 
quirements for responses to H-2 antigens and soluble protein antigens. 
As shown in Fig. 2, synergism occurs only at limiting numbers of nu/+  LN 
cells in the slope 2 region of a log-log plot. The observation that addition of nu/ 
nu spleen cells changes slope 2 of a log-log plot into slope 1 (Fig. 2) suggests that 
the cell type being diluted out in nu/+ LN is the same as the non-T cell in nu/nu 
spleen accounting for the synergism (47). 
Studies of the active cell in nu/nu  spleen using velocity sedimentation cell 
separation, coupled with measurements of radiosensitivity and adherence prop- 
erties indicate" that the major activity is due to a relatively radiation sensitive, 
nonadherent cell population with modal sedimentation velocity of 4.2 mm/h. In 
addition, there is a minor subpopulation of relatively radioresistant active cells 
with modal sedimentation velocity of about 6 mm/h. The observed sedimenta- 
tion profiles are inconsistent with the active cells being B cells (48), but have 
similarities to the profiles measured for A cells (49, 50). Similar active cells can 
be  seen  in  the  spleen,  LN,  and  peritoneal  cells  of normal  mice  (work  in 
progress). 
Summary 
The ability of small numbers of LN cells to produce cytotoxic lymphocytes on 
in vitro culture with allogeneic stimulator cells is greatly augmented by the 
addition  of spleen  cells  from  athymic  nude  mice.  The  possibility  that  the 
synergism is  a  result  of improved  culture  conditions  or  a  "feeder effect" is 
.2 Miller, R. G.,  R.  M. Schilling, and R. A. Phillips. Manuscript in preparation. 256  NON-T  CELLS  IN  THE  GENERATION  OF  CYTOTOXIC  T  LYMPHOCYTES 
excluded. All cytotoxic cells found in these cultures are shown to be T  cells and 
to arise from precursors contained in the LN-cell component.  The nude spleen 
cell component appears to be providing a required non-T cell which has been lost 
from the  LN component through dilution.  Synergism between the two compo- 
nents can occur whether they are syngeneic or allogeneic provided that both can 
recognize the same alloantigens in the stimulator population. 
Received for publication 17 February 1976. 
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